The anti-cancer effects of (-)-Epigalocathine-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2721-2730

  Hsu, Yuan Chang ^a   Liou, Ying Ming ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CALCIUM ION; CASPASE 3; ENHANCED GREEN FLUORESCENT PROTEIN; EPIDERMAL GROWTH FACTOR; EPIGALOCATHINE 3 GALLATE; FATTY ACID SYNTHASE; GELSOLIN; LAMININ; LAMININ RECEPTOR; MEMBRANE RECEPTOR; MESSENGER RNA; OSTEOPONTIN; TROPOMYOSIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL JUNCTION; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CALCIUM; CATECHIN; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION;

EID: 79960693011     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22623     Document Type: Article

References (38)

1. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein IB. 2007. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 67: 6493-6501.
2. Akiyama T, Ogawara H. 1991. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201: 362-370.
3. Andl CD, Rustgi AK. 2005. No one-way street: Cross-talk between e-cadherin and receptor tyrosine kinase (RTK) signaling: A mechanism to regulate RTK activity. Cancer Biol Ther 4: 28-31.
4. Bach CT, Creed S, Zhong J, Mahmassani M, Schevzov G, Stehn J, Cowell LN, Naumanen P, Lappalainen P, Gunning PW, O'Neill GM. 2009. Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction. Mol Cell Biol 29: 1506-1514.
5. Dashwood WM, Carter O, Al-Fageeh M, Li Q, Dashwood RH. 2005. Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat Res 591: 161-172.
6. Daugherty RL, Gottardi CJ. 2007. Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology 22: 303-309.
7. Dohn MR, Brown MV, Reynolds AB. 2009. An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth. J Cell Biol 184: 437-450.
8. Duhon D, Bigelow RL, Coleman DT, Steffan JJ, Yu C, Langston W, Kevil CG, Cardelli JA. 2010. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol Carcinog 49: 739-749.
9. Frame MC. 2004. Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989-998.
10. Fujimura Y, Umeda D, Kiyohara Y, Sunada Y, Yamada K, Tachibana H. 2006. The involvement of the 67kDa laminin receptor-mediated modulation of cytoskeleton in the degranulation inhibition induced by epigallocatechin-3-O-gallate. Biochem Biophys Res Commun 348: 524-531.
11. Gross JC, Schreiner A, Engels K, Starzinski-Powitz A. 2009. E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1. Mol Biol Cell 20: 3598-3607.
12. Gunning P, O'Neill G, Hardeman E. 2008. Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 88: 1-35.
13. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. 2005. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85: 979-1000.
14. Hedley BD, Welch DR, Allan AL, Al-Katib W, Dales DW, Postenka CO, Casey G, Macdonald IC, Chambers AF. 2008. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int J Cancer 123: 526-534.
15. Huelsken J, Birchmeier W. 2001. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 11: 547-553.
16. Johnstone RW, Ruefli AA, Lowe SW. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108: 153-164.
17. Kamada S, Kusano H, Fujita H, Ohtsu M, Koya RC, Kuzumaki N, Tsujimoto Y. 1998. A cloning method for caspase substrates that uses the yeast two-hybrid system: Cloning of the antiapoptotic gene gelsolin. Proc Natl Acad Sci USA 95: 8532-8537.
18. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66: 2500-2505.
19. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. 1997. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278: 294-298.
20. Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M. 2003. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 63: 8118-8121.
21. Li Y, Sarkar FH. 2002. Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8: 2369-2377.
22. Lilien J, Balsamo J. 2005. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 17: 459-465.
23. Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, Timson DJ. 2008. The 67kDa laminin receptor: Structure, function and role in disease. Biosci Rep 28: 33-48.
24. Pahlke G, Ngiewih Y, Kern M, Jakobs S, Marko D, Eisenbrand G. 2006. Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem 54: 7075-7082.
25. 2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 101: 17404-17409.
26. Patra SK. 2008. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785: 182-206.
27. Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S. 2008. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts. J Physiol Pharmacol Suppl 9: 217-235.
28. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL. 2003. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 2: 6194-6203.
29. Shieh DB, Li RY, Liao JM, Chen GD, Liou YM. 2010. Effects of genistein on β-catenin signaling and subcellular distribution of actin-binding proteins in human umbilical CD105-positive stromal cells. J Cell Physiol 223: 423-434.
30. Tachibana H, Koga K, Fujimura Y, Yamada K. 2004. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11: 380-381.
31. Umeda D, Tachibana H, Yamada K. Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67kDa laminin receptor. Biochem Biophys Res Commun 333: 628-635.
32. Umeda D, Yano S, Yamada K, Tachibana H. 2008. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 283: 3050-3058.
33. Wang CL, Coluccio LM. 2010. New insights into the regulation of the actin cytoskeleton by tropomyosin. Int Rev Cell Mol Biol 281: 91-128.
34. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. 2005. Deconstructing the cadherin-catenin-actin complex. Cell 123: 889-901.
35. Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, Lin JK. 2003. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: A possible mechanism for their hypolipidemic effects. Pharmacogenomics J 3: 267-276.
36. Yin HL, Stossel TP. 1979. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 281: 583-586.
37. Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, Zhang J. 2009. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Eur J Pharmacol 606: 172-179.
38. Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.